|
Volumn 12, Issue 6, 2013, Pages 411-412
|
Integrin inhibitors go with the gut
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMG 181;
ESTROLIZUMAB;
GASTROINTESTINAL AGENT;
MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1;
NATALIZUMAB;
ORBOFIBAN;
TOFACITINIB;
UNCLASSIFIED DRUG;
USTEKINUMAB;
VASCULAR CELL ADHESION MOLECULE 1;
VEDOLIZUMAB;
VERCIRNON;
VERY LATE ACTIVATION ANTIGEN 4;
XEMILOFIBAN;
INTEGRIN;
MONOCLONAL ANTIBODY;
CROHN DISEASE;
DISEASE SEVERITY;
DRUG APPROVAL;
ENTERITIS;
EXTRACELLULAR MATRIX;
HUMAN;
IMMUNOSURVEILLANCE;
LYMPHOCYTE MIGRATION;
MEMORY T LYMPHOCYTE;
PRIORITY JOURNAL;
SHORT SURVEY;
ULCERATIVE COLITIS;
ANIMAL;
DRUG ANTAGONISM;
GASTROINTESTINAL DISEASE;
METABOLISM;
NOTE;
ANIMALS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
GASTROINTESTINAL DISEASES;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
INTEGRINS;
|
EID: 84880667585
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4037 Document Type: Short Survey |
Times cited : (4)
|
References (0)
|